Abstract:Tympanostomy tubes produce large short-term improvements in QOL for most children. The best outcomes occur when postoperative otorrhea is absent or minimal, and when parents are satisfied with their initial decision to have surgery. Further research is needed to document the long-term impact of tubes on child QOL.
“…The manual search and expert discussion yielded one extra article [28]. After applying the criteria for inclusion and exclusion, only 13 articles remained for inclusion [29,30,[35][36][37][38][39][40][41][42][43][44]. In addition, we included results regarding reliability and validity of the TAIQOL from our own work published in a thesis [45].…”
Section: Resultsmentioning
confidence: 99%
“…The setting of the studies varied, eight studies were part of a multi-centre trial [28,35,37,38,41,[43][44][45]. Most study-populations consisted of children with chronic or recurrent otitis media ( Table 2).…”
SummaryBackground: Growing interest in health-related quality of life (HRQoL) in children with otitis media has brought the need to study the currently available HRQoL instruments with respect to their results and their applicability in clinical practice and research of otitis media. Objective: To review existing literature on health-related quality of life research in children with otitis media with respect to: (1) the measured impact of otitis media on HRQoL; and (2) the applicability of HRQoL instruments used in research and clinical practice based on their characteristics and contents.
“…The manual search and expert discussion yielded one extra article [28]. After applying the criteria for inclusion and exclusion, only 13 articles remained for inclusion [29,30,[35][36][37][38][39][40][41][42][43][44]. In addition, we included results regarding reliability and validity of the TAIQOL from our own work published in a thesis [45].…”
Section: Resultsmentioning
confidence: 99%
“…The setting of the studies varied, eight studies were part of a multi-centre trial [28,35,37,38,41,[43][44][45]. Most study-populations consisted of children with chronic or recurrent otitis media ( Table 2).…”
SummaryBackground: Growing interest in health-related quality of life (HRQoL) in children with otitis media has brought the need to study the currently available HRQoL instruments with respect to their results and their applicability in clinical practice and research of otitis media. Objective: To review existing literature on health-related quality of life research in children with otitis media with respect to: (1) the measured impact of otitis media on HRQoL; and (2) the applicability of HRQoL instruments used in research and clinical practice based on their characteristics and contents.
“…In particular, several studies have been published investigating the effect of tympanostomy tube placement on their FHS, with some showing a positive effect 5,45,48,49 and others not. 50 Trials on tympanostomy tube placement, however, are hampered by the inability to blind caregivers and children for treatment, which means that treatment effects may be at least in part biased by their expectations.…”
“…207 Tympanostomy tube insertion has been shown to improve diseasespecific quality-of-life measures in children with OM. 208 One multicenter, nonrandomized observational study showed large improvements in a disease-specific quality-of-life instrument that measured psychosocial domains of physical suffering, hearing loss, speech impairment, emotional distress, activity limitations, and caregiver concerns that are associated with ear infections. 209 These benefits of tympanostomy tubes have been demonstrated in mixed populations of children that include children with OME as well as recurrent AOM.…”
This evidence-based clinical practice guideline is a revision of the 2004 acute otitis media (AOM) guideline from the American Academy of Pediatrics (AAP) and American Academy of Family Physicians. It provides recommendations to primary care clinicians for the management of children from 6 months through 12 years of age with uncomplicated AOM.In 2009, the AAP convened a committee composed of primary care physicians and experts in the fields of pediatrics, family practice, otolaryngology, epidemiology, infectious disease, emergency medicine, and guideline methodology. The subcommittee partnered with the Agency for Healthcare Research and Quality and the Southern California Evidence-Based Practice Center to develop a comprehensive review of the new literature related to AOM since the initial evidence report of 2000. The resulting evidence report and other sources of data were used to formulate the practice guideline recommendations.The focus of this practice guideline is the appropriate diagnosis and initial treatment of a child presenting with AOM. The guideline provides a specific, stringent definition of AOM. It addresses pain management, initial observation versus antibiotic treatment, appropriate choices of antibiotic agents, and preventive measures. It also addresses recurrent AOM, which was not included in the 2004 guideline. Decisions were made on the basis of a systematic grading of the quality of evidence and benefit-harm relationships.The practice guideline underwent comprehensive peer review before formal approval by the AAP.This clinical practice guideline is not intended as a sole source of guidance in the management of children with AOM. Rather, it is intended to assist primary care clinicians by providing a framework for clinical decision-making. It is not intended to replace clinical judgment or establish a protocol for all children with this condition. These recommendations may not provide the only appropriate approach to the management of this problem. Pediatrics 2013;131:e964-e999
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.